This list is based on the watchlists of people on Stock Events who follow ONCO.BOATS. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Onconetix, Inc., a biotechnology company, focuses on the research, development, and commercialization of solutions for men's health and oncology. It offers Entadfi, an FDA-approved, once daily pill that combines finasteride and tadalafil for the treatment of benign prostatic hyperplasia; and Proclarix, an in vitro protein-based blood diagnostic test for prostate cancer. The company was formerly known as Blue Water Biotech, Inc. and changed its name to Onconetix, Inc. in December 2023. Onconetix, Inc. was incorporated in 2018 and is headquartered in Cincinnati, Ohio.
The current price of ONCO.BOATS is $0.88 USD — it has increased by +13.68% in the past 24 hours. Watch Onconetix stock price performance more closely on the chart.
What is Onconetix stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Onconetix stocks are traded under the ticker ONCO.BOATS.
What is Onconetix market cap?▼
Today Onconetix has the market capitalization of 1.37M
When is the next Onconetix earnings date?▼
Onconetix is going to release the next earnings report on May 11, 2026.
What is Onconetix revenue for the last year?▼
Onconetix revenue for the last year amounts to 5.05M USD.
What is Onconetix net income for the last year?▼
ONCO.BOATS net income for the last year is -117.79M USD.
In which sector is Onconetix located?▼
Onconetix operates in the Other sector.
When did Onconetix complete a stock split?▼
The last stock split for Onconetix was on March 25, 2026 with a ratio of 1:5.